JPS5856692A - Preparation of hyaluronic acid - Google Patents

Preparation of hyaluronic acid

Info

Publication number
JPS5856692A
JPS5856692A JP15235581A JP15235581A JPS5856692A JP S5856692 A JPS5856692 A JP S5856692A JP 15235581 A JP15235581 A JP 15235581A JP 15235581 A JP15235581 A JP 15235581A JP S5856692 A JPS5856692 A JP S5856692A
Authority
JP
Japan
Prior art keywords
hyaluronic acid
streptococcus
medium
glucose
carbon source
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP15235581A
Other languages
Japanese (ja)
Other versions
JPH0412960B2 (en
Inventor
Hidemichi Akasaka
赤坂 日出道
Hisayuki Komazaki
駒崎 久幸
Mitsuo Yanagi
柳 光男
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to JP15235581A priority Critical patent/JPS5856692A/en
Publication of JPS5856692A publication Critical patent/JPS5856692A/en
Publication of JPH0412960B2 publication Critical patent/JPH0412960B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PURPOSE:To prepare the titled substance, by culturing hyaluronic acid-producing bacteria belonging to Streptococcus genus in a nutrient medium containing more than specific amount of a saccharide component as a main carbon source, and separating the objective substance produced and accumulated in the medium. CONSTITUTION:Hyaluronic acid-producing bacteria belonging to Streptococcus genus, e.g. Streptococcus pyogenes, Streptococcus equi, Streptococcus equisimilis, etc. are cultured in a medium containing >=3% saccharide component such as glucose, sucrose, galactose, etc. as a main carbon source, and a nitrogen source, inorganic salts, minor organic nutrients, etc. under aeration and agitation, and the accumulated hyaluronic acid is separated from the medium. The separation can be carried out by conventional method for the separation of polysaccharides.

Description

【発明の詳細な説明】 本発明は微生物によるヒアルロン酸の製造方法に関する
ものである〇 従来・ヒアルロン酸はウシの眼のガラス液・ニワトリの
トサカ、このほか謄帯、関節液等より単離され、タンパ
ク質および水と結合してゼリー状を保ち、潤滑剤的な役
割、バクテリアの侵入からの保護、水分の保持等に役立
っている。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing hyaluronic acid using microorganisms. Conventionally, hyaluronic acid has been isolated from cow eye glass fluid, chicken crest, umbilical cord, synovial fluid, etc. It binds with protein and water to maintain a jelly-like state, acting as a lubricant, protecting against bacterial invasion, and retaining moisture.

しかし、極めて高価であることが問題点であった。However, the problem was that it was extremely expensive.

一方ストレプトコ、カス属細菌を利用したヒアルロン噌
の生成についてはストレブトフ、カス・ピオゲネス(5
treptococcus pyogenea ) 、
ストレブトコ、カス・エキ(5treptococcu
s equi ) 、ストレブトコ 、カ ス ・ エ
 キーシ ミ リ ス (5treptococcus
 equiaimilis )ストレブトコ、カス・デ
ィスガラクチイエ(5tr8ptococcus dy
sgalactiae )およびストレプトコ。
On the other hand, regarding the production of hyaluronan using bacteria of the genus Streptococcus and Kas, Strebutov and Kas pyogenes (5
treptococcus pyogenea),
Strebutco, Kas Eki (5treptococcu)
sequi), strebtococcus, cas.
equiaimilis) Strebutco, Kas disgalactiie (5tr8ptococcus dy
sgalactiae) and streptococcus.

カス・ズーエピデミカス(5treptococcus
 zooepidemicus)等の細菌によりヒアル
ロン酸を生産する事がすでに知られている。その報告は
ホルムストレーム(E、Ho1m5trδm Appl
、Microbial 1967) 、ジェー・ピー・
ウールコ、り(、T、B、Woolcock 85.3
72 ヘ375 J、Gen。
Cas zooepidemicus (5treptococcus)
It is already known that hyaluronic acid is produced by bacteria such as B. zooepidemicus. The report was published by Holmström (E, Ho1m5trδm Appl.
, Microbial 1967), J.P.
Woolcock, Ri (, T, B, Woolcock 85.3
72 He375 J, Gen.

Microbial 1974 ) 、イー・キエム(
E、Kjem Acta Pathol。
Microbial 1974), Lee Kiem (
E, Kjem Acta Pathol.

Microbial、5cand 1976)らによっ
てすでに報告されている。しかしいずれも大量生産を目
的としたものではなく、グルコース1%、培養時間M時
間、pH70〜76、温度30〜376C等の条件で行
なうもので収量は0.6g//以下と低いものであった
Microbial, 5cand 1976) et al. However, none of them are intended for mass production, and are carried out under conditions such as glucose 1%, culture time M hours, pH 70 to 76, and temperature 30 to 376 C, and the yield is low at 0.6 g// or less. Ta.

本発明者らは簡単で安価な培地でヒアルロン酸を収量良
く安定に生成せしめる事を意図して鋭意研究した結果、
特定の条件で上記細菌を培養する即ち、本発明は糖成分
3%以上を主炭素源とする栄養培地にてストレプトコツ
カス属のヒアルロン酸を生成する能力を有する微生物を
通気攪拌培養し、培養液中にヒアルロン酸を生成せしめ
、これを採取するものである。
The present inventors conducted extensive research with the intention of stably producing hyaluronic acid in good yields using a simple and inexpensive medium.
Cultivating the above-mentioned bacteria under specific conditions That is, the present invention involves culturing with aeration agitation of a microorganism of the genus Streptococcus that has the ability to produce hyaluronic acid in a nutrient medium containing 3% or more of sugar components as the main carbon source. Hyaluronic acid is produced in the liquid and collected.

(以下余白) 1!I開口R58−50G92(2) 本発明のヒアルロン酸を生産する能力を有する細菌とし
てはストレプトコッカス・ピオゲネス、ストレプトコッ
カス・エキ、ストレプトコッカス・エキシミリス、スト
レプトコッカス・ディスガラクチイエ、ストレプトコッ
カス・ズーエピデミカス等があげられる。
(Left below) 1! I-opening R58-50G92 (2) Bacteria having the ability to produce hyaluronic acid of the present invention include Streptococcus pyogenes, Streptococcus equi, Streptococcus excimilis, Streptococcus dysgalactiae, Streptococcus zooepidemicus, and the like.

本発明においてヒアルロン酸の生産は上記ヒアルロン酸
生産菌を特定の栄養培地にて培養することにより行なわ
れる。培地としては・炭素源・t−素源、無機塩及びそ
の他に必要ならば有機微量栄養素を含有する培地がよい
。炭素源としては例えば有機酸、脂肪族アルコール等い
ろいろあるが本発明では澱粉加水分解物、グルコース・
蔗糖・ガラクトース、7ラクトース等の糖分が必須成分
と各種アミノ酸混合物、酵母エキス等の一般的な源料が
用いられる。
In the present invention, production of hyaluronic acid is carried out by culturing the above-mentioned hyaluronic acid-producing bacteria in a specific nutrient medium. As a medium, a medium containing a carbon source, a t-source, an inorganic salt, and other organic micronutrients if necessary is preferable. There are various carbon sources such as organic acids and aliphatic alcohols, but in the present invention, starch hydrolysates, glucose, etc.
Common sources such as essential sugars such as sucrose, galactose, and 7-lactose, mixtures of various amino acids, and yeast extract are used.

さらにこの他に塩化ナトリウム、あるいはマグネシウム
、カリウム、鉄、カルシウム等の燐酸塩硫酸塩あるいは
炭素塩等及び微量のビタミン類が必要に応じて添加され
る。
In addition, sodium chloride, phosphate sulfates or carbon salts of magnesium, potassium, iron, calcium, etc., and trace amounts of vitamins are added as necessary.

ヒアルロン酸の収量増加には炭素源のうちグルコースを
用いると特に良い結果が得られる。糖の添加は一度に多
量添加するよりも少量に分割して適時添加する方が良い
結果となる。糖の濃度は3%以上添加するとヒアルロン
酸の生産量が1%の時に比べ顕著に増加する。その濃麻
は6〜8%添加すれば十分で、これ以上添加しても収量
の増加はない。3%未満では本発明の効果は発揮出来な
添加量を変えて培養した結果を表−■に示した。
Particularly good results can be obtained when glucose is used as a carbon source to increase the yield of hyaluronic acid. When adding sugar, it is better to divide it into small amounts and add it at appropriate times than to add a large amount at once. When the concentration of sugar is 3% or more, the amount of hyaluronic acid produced increases significantly compared to when the sugar concentration is 1%. It is sufficient to add 6 to 8% of the thick hemp, and adding more will not increase the yield. If the amount is less than 3%, the effect of the present invention cannot be achieved.Table 2 shows the results of culturing with varying amounts of addition.

グルコース3%以上添加の場合は1%と比較するとかな
り収量が増加する事が分かる。
It can be seen that when 3% or more glucose is added, the yield increases considerably compared to 1%.

すなわち、 表−1培地組成の比較 PH55−9,OS湿度刀〜44°02通気i 1〜2
 l/mix培養時間(1〜4日) グルコース8%添加時のヒアルロン酸の収量は常法に従
い精製した結果40り/lであった。
That is, Table 1: Comparison of medium composition PH55-9, OS humidity blade ~44°02 ventilation i 1-2
l/mix culture time (1 to 4 days) The yield of hyaluronic acid when 8% glucose was added was 40 l/l as a result of purification according to a conventional method.

培養時においては通気攪拌が必須である。通気攪拌の方
法としては振とう培養あるいは空気吹込みによる通常の
通気攪拌培養があるが、いずれを使用してもよい。その
際、攪拌力は弱く、通気量を多くした方が良い結果が得
られる。通気の有無を表−Hに示す。通気する事によっ
て収量が明らかに増加することが分かる。
Aeration and stirring are essential during culture. Methods for aeration and agitation include shaking culture and normal aeration and agitation culture using air blowing, either of which may be used. In this case, better results can be obtained by using a weak stirring force and increasing the amount of aeration. Table H shows the presence or absence of ventilation. It can be seen that the yield clearly increases by aeration.

さらに培養時に、アルカリ水浴液にてpHを55〜90
に調整するとヒアルロン酸が安定に生成出来、より好ま
しい。アルカリ水溶液どしては水酸化ナトリウム・水酸
化カリウム・塩基性アミノ酸・低級アミン等の通常用い
られるアルカリの単独あるいは混合溶液が使用出来る。
Furthermore, during culturing, adjust the pH to 55-90 using an alkaline water bath.
When adjusted to , hyaluronic acid can be stably produced, which is more preferable. As the alkaline aqueous solution, a single or mixed solution of commonly used alkalis such as sodium hydroxide, potassium hydroxide, basic amino acids, lower amines, etc. can be used.

培養後培養液中に蓄積されたヒアルロン酸を分離、採取
するにあたっては、培地を酸性にして処理すると純度が
よくなり処理しやすい。
When separating and collecting hyaluronic acid accumulated in the culture medium after culturing, the medium is made acidic to improve its purity and make it easier to process.

ヒアルロン酸の分離には従来から行われている多糖類の
分離採取法が利用出来る・ 例えば培養液中の菌体、その他の不溶成分は濾過又は遠
心分離等により分離除去する。溶液中に混在する蛋白質
はトリクロル酢酸、又はクロロホルム、イソアミルアル
コール混液での除去あるいは活性白土、活性炭等の吸着
剤あるいはペプシン、パパイン、プロナーゼ等の蛋白質
分解酵素にて除去することが出来る。
Conventional methods for separating and collecting polysaccharides can be used to separate hyaluronic acid. For example, bacterial cells and other insoluble components in the culture solution are separated and removed by filtration or centrifugation. Proteins mixed in the solution can be removed with a mixture of trichloroacetic acid, chloroform, and isoamyl alcohol, or with an adsorbent such as activated clay or activated carbon, or with a proteolytic enzyme such as pepsin, papain, or pronase.

また、混在する低分子物質は限外濾過、透析あるいは有
機溶媒再沈法等により分離除去する0そ出来る、 このようにして得られたヒアルロン酸は水に可溶、メタ
ノール、エタノール、アセトン、クロロホルム、エーテ
ル等の有機溶媒には不溶の白色繊維状、無味、無臭の乾
燥物である。
In addition, mixed low-molecular substances can be separated and removed by ultrafiltration, dialysis, or organic solvent reprecipitation.The hyaluronic acid obtained in this way is soluble in water, methanol, ethanol, acetone, and chloroform. It is a white, fibrous, tasteless, odorless dry product that is insoluble in organic solvents such as ether.

べる。Bell.

呈色反応 アンスロン−硫酸反応:緑色 カルバゾール−硫酸反応: arE色 赤外吸収スペクトル KBr錠剤法で測定した赤外線吸収スペクトルは第1図
の通りである。
Color reaction Anthrone-sulfuric acid reaction: Green carbazole-sulfuric acid reaction: arE color infrared absorption spectrum The infrared absorption spectrum measured by the KBr tablet method is shown in FIG.

01%水溶液の比旋光度:〔α〕苫−−675゜電気泳
動による分析 等速電気泳動のチャートを第2図に示した。
Specific optical rotation of 01% aqueous solution: [α] - 675° Analysis by electrophoresis A chart of isotachophoresis is shown in FIG.

泳動条件は下記の通りで、本多糖のボテンシフルユニ、
トバリa  (potential Unit Val
ue )は023であるところから、本粘質物はヒアル
ロン酸であることを確認した。
The electrophoresis conditions were as follows.
Tobaria (potential Unit Val
ue ) was 023, which confirmed that the mucilage was hyaluronic acid.

又、セルロースアセテ−、ト膜を用いるろ紙電気泳動法
でも0.1M酢酸亜鉛電極液で本多糖はヒアルロン酸と
一致した。その際、真菌性ヒアルロニダーゼ(stre
ptomyces hyalurolyticus )
で処理後電気泳動にて分析したものは標品と同様スボ、
トを示さず、本酵素により分解される事からもヒアルロ
ン酸である事が確認出来た。
Also, in filter paper electrophoresis using a cellulose acetate membrane, this polysaccharide was found to be identical to hyaluronic acid using a 0.1 M zinc acetate electrode solution. At that time, fungal hyaluronidase (stre
ptomyces hyalurolyticus)
The samples analyzed by electrophoresis after being treated with
It was confirmed that it was hyaluronic acid because it was degraded by this enzyme and showed no oxidation.

実施例1 グルコース8%、酵母エキスo5%、ペプトン15%、
リン1酸第1水素カリウム02%、チオ硫酸ナトリウム
611%、亜硫酸ナトリウム002%の組成のの培地を
l/のジャーファーメンタ−(いわしや製MA型50−
ミニジャー)に40−分注し、120°C115分間加
熱殺菌後・前培養したストレプトコッカス・ズーエピデ
ミカスを接種し、p)I 7 、33°Cで4日間通気
攪拌(通気量2t、′min、回転数200rpm )
培養した。
Example 1 Glucose 8%, yeast extract O5%, peptone 15%,
A medium with a composition of 02% potassium monohydrogen phosphate, 611% sodium thiosulfate, and 002% sodium sulfite was placed in a jar fermenter (MA type 50, manufactured by Iwashiya).
After heat sterilizing at 120°C for 115 minutes and inoculating with pre-cultured Streptococcus zooepidemicus, the mixture was aerated and stirred at 33°C for 4 days (aeration volume 2t, 'min, rotation speed). 200rpm)
Cultured.

、培養終了後培養液より遠心分離により、菌体及びその
他の夾雑物を除去し、上澄液へ2倍量のエタノールを攪
拌しつつ加えると繊維状物質が沈殿した。これを戸別し
た後、エーテル、ついでエタノールで充分洗浄後、再び
水に溶解し、セチルピリジニウムクロライドを加え、生
じた沈殿を戸数し・水およびO,1M Na0j水溶液
にて十分洗浄後0.5MNaC7にてヒアルロン酸を抽
出し、その溶液を透析法により脱塩後、溶液を凍結乾燥
して培養液11より40gのヒアルロン酸を得た。本品
はp紙電気泳動にて標品のヒアルロン酸と同じ位置に泳
動され・等速電気泳動のユ斤、トバリ、−も0.23と
標品のそれと一致した。さらに赤外線吸収スペクトルモ
檜品のスペクトルと一致シタ。
After completion of the culture, the bacterial cells and other impurities were removed from the culture solution by centrifugation, and when twice the amount of ethanol was added to the supernatant with stirring, fibrous substances were precipitated. After taking this from house to house, thoroughly washing it with ether and then ethanol, dissolving it again in water, adding cetylpyridinium chloride, and taking the resulting precipitate from house to house, thoroughly washing it with water and O, 1M Na0j aqueous solution, and dipping it into 0.5M NaC7. After extracting hyaluronic acid and desalting the solution by dialysis, the solution was freeze-dried to obtain 40 g of hyaluronic acid from culture solution 11. This product was electrophoresed in the same position as the standard hyaluronic acid by p-paper electrophoresis, and the yaw, tobar, and - values of isokinetic electrophoresis were 0.23, which matched that of the standard. Furthermore, the infrared absorption spectrum matches the spectrum of Hinoki products.

一方・グルコース8%の代りにグルコース1%添加した
培地で同様にストレプトコアカス・ズーエピデミカスを
培養した場合には、培養液11よりo、5q/lのヒア
ルロン酸が得られたにすぎなかった。
On the other hand, when Streptococcus zooepidemicus was similarly cultured in a medium to which 1% glucose was added instead of 8% glucose, only 5 q/l of hyaluronic acid was obtained from culture solution 11.

実施例2 実施例1に於て使用した培地中のグルコースの量を4%
におきかえた培地を用いてストレプトコアカス、ズーエ
ピデミカスを実施例1と同様の方法で培養した。ヒアル
ロン酸の収量は2.19/lであった◇ただし、本条件
で通気攪拌しなかった場合の収量は005り/lと低か
った。
Example 2 The amount of glucose in the medium used in Example 1 was reduced to 4%.
Streptococcus and Zooepidemicus were cultured in the same manner as in Example 1 using the replaced medium. The yield of hyaluronic acid was 2.19/l◇However, the yield when aeration and stirring under these conditions was not performed was as low as 0.005 l/l.

実施例3 実施例1に於て使用した培地中のグルコースの量を3%
におきかえた培地を用いてストレプトコアカス・ズーエ
ピデミカを実施例1と同様の方法で培養し、処理した。
Example 3 The amount of glucose in the medium used in Example 1 was reduced to 3%.
Streptococcus zooepidemica was cultured and treated in the same manner as in Example 1 using the replaced medium.

ヒアルロン酸の収量は・zOり/lであった〇 実施例4 実施例1と同様の方法でストレプトコアカス・エキ(A
 T OO9527)を培養し、培養液からヒアルロン
酸を単離精製し、培養液11より389のヒアルロン酸
を得た。
The yield of hyaluronic acid was zO/l. Example 4 Streptococcus equi (A
TOO9527) was cultured, hyaluronic acid was isolated and purified from the culture solution, and 389 hyaluronic acid was obtained from culture solution 11.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は本培養により得たヒアルロン酸の赤外線吸収ス
ペクトルである。 第2図は本培養により得たヒアルロン酸の等速電気泳動
のチャートである。 特許出願人  株式会社資生堂 年1図 Woe地艶印(、つ 1f−z図 手続補正書(自発) 昭和55年11月q日 特許庁長官 島 1)春 樹 殿 1、事件の表示 昭和元年特許願第152355号 3 補正をする者 Cm話番40  東京(a721+xxz内14211
〕4、補正の対象 明細書の「発明の詳細な説明」の欄 5 補正の内容 (1)  明細書の第4頁第17行〜189ノ’ 11
の「原料」を「原料」と補正します。 (2)  明細書の第5頁第1行目の「炭素塩」を「炭
酸塩」と補正します。 (3)明細書の第7頁第10行目め「水浴液」を「水溶
液」と補正します。 (4)明細書の第9頁第10行目の[〔α〕薯−−67
,5°」を「〔α〕□−、j57.5°」と補正します
。 (5〕  明細書の第11頁第5行目〜第6行目のl’
−17のジャーファーメンタ−(いわしや製MA−型5
00m1!ミニジャー)」を「いわしや製MA型500
m1ミニジャー」と捕正します2
FIG. 1 shows an infrared absorption spectrum of hyaluronic acid obtained by main culture. FIG. 2 is a chart of isotachophoresis of hyaluronic acid obtained by main culture. Patent applicant: Shiseido Co., Ltd. 1st figure Woe ground seal (, 1f-z figure procedural amendment (voluntary) November q, 1980 Commissioner of the Patent Office Shima 1) Tono Haruki 1, Indication of the case 1975 Patent Application No. 152355 3 Person making the amendment Cm Episode number 40 Tokyo (A721+XXZ 14211
] 4. "Detailed Description of the Invention" column 5 of the specification to be amended Contents of the amendment (1) Page 4, line 17 to line 189 of the specification 11
Correct "raw materials" to "raw materials". (2) "Carbonate" in the first line of page 5 of the specification will be corrected to "carbonate." (3) "Water bath liquid" on page 7, line 10 of the specification is corrected to "aqueous solution." (4) [[α] 薯--67 on page 9, line 10 of the specification
, 5°” is corrected to “[α]□−, j57.5°”. (5) l' on page 11, line 5 to line 6 of the specification
-17 Jarfur Mentor (MA-type 5 made by Iwashiya)
00m1! Mini jar)" to "Iwashiya MA type 500"
m1 mini jar” and capture it 2

Claims (1)

【特許請求の範囲】[Claims] (1)糖成分3%以上を主炭素源とする栄養培地にてス
トレプトコッカス属のヒアルロン酸を生成する能力を有
する微生物を通気攪拌培養して、培養液中にヒアルロン
酸を生成蓄積せしめ、これを採取することを特徴とする
微生物によるヒアルロン酸の製造方法。
(1) Streptococcus microorganisms capable of producing hyaluronic acid are cultured with aeration in a nutrient medium containing 3% or more sugar content as the main carbon source, and hyaluronic acid is produced and accumulated in the culture solution. A method for producing hyaluronic acid using a microorganism, the method comprising collecting hyaluronic acid.
JP15235581A 1981-09-26 1981-09-26 Preparation of hyaluronic acid Granted JPS5856692A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP15235581A JPS5856692A (en) 1981-09-26 1981-09-26 Preparation of hyaluronic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15235581A JPS5856692A (en) 1981-09-26 1981-09-26 Preparation of hyaluronic acid

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2866693A Division JPH0638783A (en) 1993-01-25 1993-01-25 Production of hyaluronic acid

Publications (2)

Publication Number Publication Date
JPS5856692A true JPS5856692A (en) 1983-04-04
JPH0412960B2 JPH0412960B2 (en) 1992-03-06

Family

ID=15538727

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15235581A Granted JPS5856692A (en) 1981-09-26 1981-09-26 Preparation of hyaluronic acid

Country Status (1)

Country Link
JP (1) JPS5856692A (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4517295A (en) * 1983-02-18 1985-05-14 Diagnostic, Inc. Hyaluronic acid from bacterial culture
FR2564859A1 (en) * 1984-05-25 1985-11-29 Shiseido Co Ltd PROCESS FOR THE PREPARATION OF HYALURONIC ACID BY FERMENTATION.
JPS6128503A (en) * 1983-10-11 1986-02-08 フイデイ−ア・ソシエタ・ペル・アチオニ Hyaluronic acid pharmacologically active fraction, manufacture and medicinal composition
FR2569724A1 (en) * 1984-09-04 1986-03-07 Chisso Corp PROCESS FOR THE PREPARATION OF HYALURONIC ACID
EP0211037A1 (en) * 1985-01-18 1987-02-25 Bio Technology General Corp METHOD OF PRODUCING HIGH MOLECULAR WEIGHT SODIUM HYALURONATE BY FERMENTATION OF -i(STREPTOCOCCUS).
JPS62501471A (en) * 1985-01-18 1987-06-18 バイオ−テクノロジ−・ジエネラル・コ−ポレイシヨン Method for producing high molecular weight sodium hyaluronate by fermentation of streptococci
JPS63123392A (en) * 1986-11-14 1988-05-27 Denki Kagaku Kogyo Kk Production of hyaluronic acid
JPS63156707A (en) * 1986-12-19 1988-06-29 Yakult Honsha Co Ltd Cosmetic containing hyaluronic acid
US5316926A (en) * 1983-11-25 1994-05-31 Miles Inc. Method for the microbiological production of non-antigenic hyaluronic acid
US5981509A (en) * 1997-05-20 1999-11-09 Shiseido Company, Ltd. Preparation for prophylaxis or treatment of renal diseases containing sulfated polysaccharide
CN1085728C (en) * 1993-04-16 2002-05-29 株式会社乐喜 Microorganism, medium and process for preparing hyaluronic acid
KR100472007B1 (en) * 2002-08-19 2005-03-10 주식회사 코오롱 Microorganism producing hyaluronic acid and method of producing hyalironic acid using thereof
WO2007023682A1 (en) 2005-08-25 2007-03-01 Toyo Boseki Kabushiki Kaisha Plant producing hyaluronic acid
US7575914B2 (en) 2002-08-19 2009-08-18 Kolon Life Science, Inc. Microorganism producing hyaluronic acid and purification method of hyaluronic acid
WO2012169437A1 (en) 2011-06-09 2012-12-13 三洋化成工業株式会社 Method for producing polysaccharide

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2732092C (en) 2008-07-25 2015-02-24 Denki Kagaku Kogyo Kabushiki Kaisha Method for producing hyaluronic acid

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4517295A (en) * 1983-02-18 1985-05-14 Diagnostic, Inc. Hyaluronic acid from bacterial culture
JPS6128503A (en) * 1983-10-11 1986-02-08 フイデイ−ア・ソシエタ・ペル・アチオニ Hyaluronic acid pharmacologically active fraction, manufacture and medicinal composition
JPH068323B2 (en) * 1983-10-11 1994-02-02 フイデイ−ア・ソシエタ・ペル・アチオニ Hyaluronic acid pharmacologically active fraction, method for producing the same and pharmaceutical composition
US5316926A (en) * 1983-11-25 1994-05-31 Miles Inc. Method for the microbiological production of non-antigenic hyaluronic acid
FR2564859A1 (en) * 1984-05-25 1985-11-29 Shiseido Co Ltd PROCESS FOR THE PREPARATION OF HYALURONIC ACID BY FERMENTATION.
FR2569724A1 (en) * 1984-09-04 1986-03-07 Chisso Corp PROCESS FOR THE PREPARATION OF HYALURONIC ACID
EP0211037A1 (en) * 1985-01-18 1987-02-25 Bio Technology General Corp METHOD OF PRODUCING HIGH MOLECULAR WEIGHT SODIUM HYALURONATE BY FERMENTATION OF -i(STREPTOCOCCUS).
JPS62501471A (en) * 1985-01-18 1987-06-18 バイオ−テクノロジ−・ジエネラル・コ−ポレイシヨン Method for producing high molecular weight sodium hyaluronate by fermentation of streptococci
JPH0439997B2 (en) * 1986-11-14 1992-07-01 Denki Kagaku Kogyo Kk
JPS63123392A (en) * 1986-11-14 1988-05-27 Denki Kagaku Kogyo Kk Production of hyaluronic acid
JPS63156707A (en) * 1986-12-19 1988-06-29 Yakult Honsha Co Ltd Cosmetic containing hyaluronic acid
CN1085728C (en) * 1993-04-16 2002-05-29 株式会社乐喜 Microorganism, medium and process for preparing hyaluronic acid
US5981509A (en) * 1997-05-20 1999-11-09 Shiseido Company, Ltd. Preparation for prophylaxis or treatment of renal diseases containing sulfated polysaccharide
KR100472007B1 (en) * 2002-08-19 2005-03-10 주식회사 코오롱 Microorganism producing hyaluronic acid and method of producing hyalironic acid using thereof
US7575914B2 (en) 2002-08-19 2009-08-18 Kolon Life Science, Inc. Microorganism producing hyaluronic acid and purification method of hyaluronic acid
WO2007023682A1 (en) 2005-08-25 2007-03-01 Toyo Boseki Kabushiki Kaisha Plant producing hyaluronic acid
US8003851B2 (en) 2005-08-25 2011-08-23 Toyo Boseki Kabushiki Kaisha Plant producing hyaluronic acid
WO2012169437A1 (en) 2011-06-09 2012-12-13 三洋化成工業株式会社 Method for producing polysaccharide
US9670514B2 (en) 2011-06-09 2017-06-06 Sanyo Chemical Industries, Ltd. Method for producing polysaccharide

Also Published As

Publication number Publication date
JPH0412960B2 (en) 1992-03-06

Similar Documents

Publication Publication Date Title
JPS5856692A (en) Preparation of hyaluronic acid
JPH0378116B2 (en)
Kurane et al. Production of a bioflocculant by mixed culture
CA1157408A (en) Polysaccharides and process therefor
Cohen et al. Extracellular polysaccharides of Azotobacter vinelandii
GB2249315A (en) A process for producing an aqueous solution of sodium hyaluronate
KR19980080116A (en) Purification Method of Sodium Hyaluronate
Spencer et al. The occurrence in the host plant of physiologically active gums produced by Corynebacterium insidiosum and Corynebacterium sepedonicum
EP0030393A1 (en) Xanthanase enzyme and its production
Bailey Transglucosidase activity of rumen strains of Streptococcus bovis: structure of the dextran produced from sucrose
Zähringer et al. Structure of a new 6-deoxy-α-d-talan from Burkholderia (Pseudomonas) plantarii strain DSM 6535, which is different from the O-chain of the lipopolysaccharide
US3396082A (en) Glucan production by fermentation of fleshy fungi
Sømme Chemical analysis of exocellular, acid polysaccharides from seven Rhizobium strains
JP3865801B2 (en) Novel β-agarase, process for producing the same and use thereof
DE69420704T2 (en) ALTEROMONA TYPE BACTERIA, POLYSACCHARIDES PRODUCED BY THESE BACTERIA, OSE CONTAINED IN THESE POLYSACCHARIDES AND THEIR APPLICATIONS
JPS62209091A (en) Antitumor active polysaccharide
JPS61219394A (en) Production of hyaluronic acid through fermentation
US3879546A (en) Saccharase inhibitors
JPH0638783A (en) Production of hyaluronic acid
KR890002256B1 (en) Process for preparing anticanser tf-2
PL91664B1 (en)
Yamada et al. Polysaccharides of the cellular slime mold I. Extracellular polysaccharides in growth phase of Dictyostelium discoideum
JPS6251999A (en) Production of hyaluronic acid
JPH0630603B2 (en) Hyaluronic acid manufacturing method
JPS62257393A (en) Production of hyaluronic acid